| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
111.48 |
22.3 |
133.78 |
4% |
4.46 |
115.94 |
23.19 |
139.13 |
16% |
17.84 |
133.78 |
26.76 |
160.54 |
|
НСР-4898/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L.,Италия |
111.48 |
22.3 |
133.78 |
4% |
4.46 |
115.94 |
23.19 |
139.13 |
16% |
17.84 |
133.78 |
26.76 |
160.54 |
|
НСР-3604/23.05.2014 |
06.06.2014 |
06.06.2014 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy |
113.83 |
22.77 |
136.6 |
4% |
4.55 |
118.38 |
23.68 |
142.06 |
16% |
18.21 |
136.59 |
27.32 |
163.91 |
|
НСР-2498/24.01.2014 |
12.02.2014 |
12.02.2014 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy |
37.94 |
7.59 |
45.53 |
4% |
1.52 |
39.46 |
7.89 |
47.35 |
16% |
6.07 |
45.53 |
9.11 |
54.64 |
|
НСР-2498/24.01.2014 |
12.02.2014 |
12.02.2014 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L.,Италия |
121.24 |
24.25 |
145.49 |
4% |
4.85 |
126.09 |
25.22 |
151.31 |
16% |
19.4 |
145.49 |
29.1 |
174.59 |
|
НСР-1036/23.08.2013 |
11.09.2013 |
11.09.2013 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy |
132.72 |
26.54 |
159.26 |
4% |
5.31 |
138.03 |
27.61 |
165.64 |
16% |
21.24 |
159.27 |
31.85 |
191.12 |
корекц. КЦPP-2717/20.03.2013 |
КЦРР-2413/22.02.2013 |
17.04.2013 |
17.04.2013 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy |
44.24 |
8.85 |
53.09 |
4% |
1.77 |
46.01 |
9.2 |
55.21 |
16% |
7.08 |
53.09 |
10.62 |
63.71 |
корекц. КЦPP-2717/20.03.2013 |
КЦРР-2413/22.02.2013 |
17.04.2013 |
17.04.2013 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Ирландия |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
35.19 |
7.04 |
42.23 |
4% |
1.41 |
36.6 |
7.32 |
43.92 |
16% |
5.63 |
42.23 |
8.45 |
50.68 |
Промяна на обстоятелства НСР-20070/30.10.2019 |
НСР-4899/22.10.2014; НСР-9829/21.07.2016; НСР-12835/26.05.2017; НСР-15143/02.03.2018 |
17.03.2018 |
02.12.2019 |
Активен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
35.19 |
7.04 |
42.23 |
4% |
1.41 |
36.6 |
7.32 |
43.92 |
16% |
5.63 |
42.23 |
8.45 |
50.68 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016; НСР-12835/26.05.2017; НСР-15143/02.03.2018 |
17.03.2018 |
02.04.2018 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
36.81 |
7.36 |
44.17 |
4% |
1.47 |
38.28 |
7.66 |
45.94 |
16% |
5.89 |
44.17 |
8.83 |
53 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016; НСР-12835/26.05.2017 |
10.06.2017 |
02.07.2017 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
36.87 |
7.37 |
44.24 |
4% |
1.47 |
38.34 |
7.67 |
46.01 |
16% |
5.9 |
44.24 |
8.85 |
53.09 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016 |
02.09.2016 |
02.09.2016 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
36.87 |
7.37 |
44.24 |
4% |
1.47 |
38.34 |
7.67 |
46.01 |
16% |
5.9 |
44.24 |
8.85 |
53.09 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016 |
02.09.2016 |
02.09.2016 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
37.16 |
7.43 |
44.59 |
4% |
1.49 |
38.65 |
7.73 |
46.38 |
16% |
5.95 |
44.6 |
8.92 |
53.52 |
|
НСР-4899/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
37.16 |
7.43 |
44.59 |
4% |
1.49 |
38.65 |
7.73 |
46.38 |
16% |
5.95 |
44.6 |
8.92 |
53.52 |
|
НСР-4899/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3265 |
| Metoclopramide |
20160367 |
Elitan, Solution for injection, 10 mg/2 ml, mg, Pack: 100 |
Medochemie Ltd., Кипър |
Medochemie Ltd., Кипър |
97.79 |
19.56 |
117.35 |
4% |
3.91 |
101.7 |
20.34 |
122.04 |
16% |
15.65 |
117.35 |
23.47 |
140.82 |
НСР-12407/18.04.2017 и НСР-12549/28.04.2017 (предварително изпълнение) |
НСР-11549/26.01.2017 г. |
11.02.2017 |
02.05.2017 |
Активен |
15587 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
306.2 |
61.24 |
367.44 |
4% |
10 |
316.2 |
63.24 |
379.44 |
16% |
25 |
341.2 |
68.24 |
409.44 |
НСР-18704/20.05.2019 и КП-86/14.11.2019 |
НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 |
02.08.2019 |
02.01.2020 |
Активен |
15666 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
306.2 |
61.24 |
367.44 |
4% |
10 |
316.2 |
63.24 |
379.44 |
16% |
25 |
341.2 |
68.24 |
409.44 |
|
НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
15666 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/004 |
Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1224.78 |
244.96 |
1469.74 |
4% |
10 |
1234.78 |
246.96 |
1481.74 |
16% |
25 |
1259.78 |
251.96 |
1511.74 |
НСР-18709/20.05.2019 и КП-86/14.11.2019 |
НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 |
02.08.2019 |
02.01.2020 |
Активен |
15668 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/004 |
Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1224.78 |
244.96 |
1469.74 |
4% |
10 |
1234.78 |
246.96 |
1481.74 |
16% |
25 |
1259.78 |
251.96 |
1511.74 |
|
НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
15668 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/004 |
Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1224.78 |
244.96 |
1469.74 |
4% |
10 |
1234.78 |
246.96 |
1481.74 |
16% |
25 |
1259.78 |
251.96 |
1511.74 |
|
НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
15668 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
306.2 |
61.24 |
367.44 |
4% |
10 |
316.2 |
63.24 |
379.44 |
16% |
25 |
341.2 |
68.24 |
409.44 |
|
НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 |
02.08.2019 |
02.08.2019 |
Неактивен |
15666 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
316.84 |
63.37 |
380.21 |
4% |
10 |
326.84 |
65.37 |
392.21 |
16% |
25 |
351.84 |
70.37 |
422.21 |
|
НСР-12362/18.04.2017; НСР-15072/23.02.2018 |
10.03.2018 |
02.04.2018 |
Неактивен |
15666 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/004 |
Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1267.38 |
253.48 |
1520.86 |
4% |
10 |
1277.38 |
255.48 |
1532.86 |
16% |
25 |
1302.38 |
260.48 |
1562.86 |
|
НСР-12362/18.04.2017; НСР-15073/23.02.2018 |
10.03.2018 |
02.04.2018 |
Неактивен |
15668 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
352.05 |
70.41 |
422.46 |
4% |
10 |
362.05 |
72.41 |
434.46 |
16% |
25 |
387.05 |
77.41 |
464.46 |
|
НСР-12362/18.04.2017 |
03.05.2017 |
02.06.2017 |
Неактивен |
15666 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/004 |
Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1408.2 |
281.64 |
1689.84 |
4% |
10 |
1418.2 |
283.64 |
1701.84 |
16% |
25 |
1443.2 |
288.64 |
1731.84 |
|
НСР-12362/18.04.2017 |
03.05.2017 |
02.06.2017 |
Неактивен |
15668 |